Oral Presentation: Tom de Potter, MD, FEHRA
Associate Director, Cardiovascular Center Aalst, Belgium

First-In-Human results of ultra-low-temperature continuous ablation for the treatment of paroxysmal and persistent atrial fibrillation and atrial flutter.